Pharmacovigilance and Pharmacoepidemiology (Eu2P)

University of Bordeaux

Master Blended
24 months
7000 EUR/year
7000 EUR/year
Tuition fee
Apply date
Start date


The Master in Pharmacovigilance and Pharmacoepidemiology (Eu2P) from University of Bordeaux offers specializations that meet professional needs in: benefit assessment of medicines, medicine risk identification and quantification, medicine benefit-risk assessment, medicine and public health, medicine risk communication along with an “A la carte” track.


The aim of the Pharmacovigilance and Pharmacoepidemiology (Eu2P) from University of Bordeaux is to respond to the growing need for well-trained professionals in pharmacovigilance and pharmacoepidemiology highlighted by industry, regulatory and academic bodies. There is a particular need for skilled people, trained in medicine risk-benefit assessment, risk management plan elaboration, risk minimization and risk communication.

Eu2P-trained professionals are qualified for new job profiles such as project managers, pharmacoepidemiological coordinators, risk-benefit analysts and people able to interact with statisticians and clinicians. Eu2P is designed for: non-specialists, graduate and postgraduate students in Health and Life Sciences, healthcare professionals, companies, regulatory agencies and academic institutions.

Strengths of this Master program?

  • 100% online, open to all professionals or students throughout the world. The Master may be completed at work or at home, you do not need to travel as even the examinations are online. 70% of our students are professionals and manage their Eu2P diploma while they work full or part-time, it’s up to you!
  • The Eu2P European Master is built and recognized by all 24 academic, regulatory and industrial Eu2P partners. The courses are based on today’s job market and practices.
  • Research projects may be performed in public or private environments.
  • Increasing worldwide recognition for the Eu2P program as an excellent employment opportunity and also a way of improving regulatory sciences.

After this Master program?

  • Opportunities that involve collecting, monitoring, researching, assessing and evaluating information from healthcare providers and patients on the adverse effects of medications to ensure that drugs on the market are safe for patients and to identify new hazards associated with the medication.
  • Students are generally in either full or part-time employment and are likely to have a range of responsibilities, mostly in pharmacovigilance and medical information, monitoring safety data in either pre- or post-marketing studies or from spontaneous reports. Pharmacovigilance is an expanding area, primarily due to an increase in regulation and product withdraws based on safety concerns.
  • Following registration to Eu2P, students are invited to join the Alumni group via which they regularly receive job offers from all over the world.

Programme Structure

Year 1:

Validation of mandatory basis modules for Pharmacovigilance and Pharmacoepidemiology

  • Completion of a tutored project (6 ECTS).
  • Validation of a research project (30 ECTS).

Year 2:

Validation of theoretical content (ten modules):

  • Six mandatory theoretical modules.
  • plus modules of the chosen track.
  • plus choice of one or two complementary optional modules.

Key information


  • Full-time
    • 24 months

Start dates & application deadlines




120 ECTS



Academic requirements

We are not aware of any academic requirements for this programme.

English requirements

We are not aware of any English requirements for this programme.

Other requirements

General requirements

If you apply to the full Master (entry in Year 1), you must:

  • have at least a Bachelor degree or an equivalent certified level in Health or Life sciences

To be eligible, you must:

  • Be fluent in English
  • Be familiar with computer use and have Internet access
  • Submit a complete on-line application, together with all supporting documentation required (diplomas, certificates, letter of motivation...) by the end of the application deadline

Tuition Fee

  • International

    7000 EUR/year
    Tuition Fee
    Based on the original amount of 7000 EUR per year and a duration of 24 months.
  • EU/EEA

    7000 EUR/year
    Tuition Fee
    Based on the original amount of 7000 EUR per year and a duration of 24 months.
  • Professionals: 12,000€/year


Studyportals Tip: Students can search online for independent or external scholarships that can help fund their studies. Check the scholarships to see whether you are eligible to apply. Many scholarships are either merit-based or needs-based.

Fresh content

Updated in the last 3 months

Check the official programme website for potential updates.

Our partners

Pharmacovigilance and Pharmacoepidemiology (Eu2P)
University of Bordeaux